☆ 4.6 Article

VSTM2L contributes to anoikis resistance and acts as a novel biomarker for metastasis and clinical outcome in ovarian cancer

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling

Hao Liu et al.

Summary: The study revealed that high expression of VSTM2L induces resistance to chemoradiotherapy in rectal cancer, leading to adverse survival outcomes. This suggests that VSTM2L high expression may serve as a potential resistant predictable biomarker for LARC patients receiving pCRT.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Add to Collection

Review Oncology

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming

Funmilayo O. Adeshakin et al.

Summary: Cancer cells develop mechanisms to resist anoikis, promoting invasion and metastasis. Understanding the mechanisms driving anoikis resistance is crucial for preventing tumor progression and metastasis, with metabolic pathways playing a key role in helping cells evade anoikis.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Fibronectin regulates anoikis resistance via cell aggregate formation

Hyeong-jun Han et al.

Summary: This study elucidated the relationship between cell aggregation and anoikis resistance, demonstrating that cell detachment increases cell aggregation and upregulates fibronectin levels. The findings suggest that increased fibronectin expression and enhanced desmosomal interactions are critical for cell aggregation and anoikis resistance upon cell detachment.

CANCER LETTERS (2021)

Add to Collection

Article Oncology

Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

David W. Chan et al.

Summary: The study revealed a significant association of global DNA hypermethylation with poor prognosis and drug resistance in high-grade EOC, while demonstrating the potential of demethylating agents in cancer treatment.

CLINICAL EPIGENETICS (2021)

Add to Collection

Review Oncology

Current insights into the metastasis of epithelial ovarian cancer-hopes and hurdles

Meysam Yousefi et al.

CELLULAR ONCOLOGY (2020)

Add to Collection

Article Reproductive Biology

Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer

Guanghui Gong et al.

JOURNAL OF OVARIAN RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer

Zhuo Zeng et al.

PEERJ (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Anoikis resistance and oncoviruses

Ehsan Kakavandi et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Add to Collection

Article Oncology

Ovarian Cancer Statistics, 2018

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Article Gastroenterology & Hepatology

Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data

Yi Hu et al.

HELICOBACTER (2018)

Add to Collection

Review Oncology

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer

Amruta P. Nayak et al.

CANCERS (2018)

Add to Collection

Article Biochemical Research Methods

Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

Julia Joung et al.

NATURE PROTOCOLS (2017)

Add to Collection

Review Oncology

Epidemiology of ovarian cancer: a review

Brett M. Reid et al.

CANCER BIOLOGY & MEDICINE (2017)

Add to Collection

Article Oncology

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation

Anna Pasto et al.

ONCOTARGET (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Anoikis molecular pathways and its role in cancer progression

Paolo Paoli et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Add to Collection

Article Cell Biology

Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis

Steven M. Frisch et al.

JOURNAL OF CELL SCIENCE (2013)

Add to Collection

Article Biochemistry & Molecular Biology

VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin

Lara Rossini et al.

FASEB JOURNAL (2011)

Add to Collection

Review Oncology

Rethinking ovarian cancer: recommendations for improving outcomes

Sebastian Vaughan et al.

NATURE REVIEWS CANCER (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.